0

Journal Articles

in Genetics
 121-140 of 844 Articles
Original Contribution |  June 15, 2011 FREE
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova, MD, MMSc; Huiliang Xie, PhD; Wei Yang, PhD; et al.
JAMA. 2011;305(23):2432-2439. doi:10.1001/jama.2011.826.
INCLUDES: , Supplemental Content
Editorial |  June 08, 2011
Cancer Risk Assessment in Lynch Syndrome:  Does the Gene Matter?
Rosa M. Xicola, PhD; Xavier Llor, MD, PhD
JAMA. 2011;305(22):2351-2352. doi:10.1001/jama.2011.771.
Original Contribution |  June 08, 2011 FREE
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valérie Bonadona, MD, PhD; Bernard Bonaïti, MSc; Sylviane Olschwang, MD, PhD; et al.
JAMA. 2011;305(22):2304-2310. doi:10.1001/jama.2011.743.
INCLUDES: , Supplemental Content
Preliminary Communication |  June 08, 2011 FREE
KIT as a Therapeutic Target in Metastatic Melanoma
Richard D. Carvajal, MD; Cristina R. Antonescu, MD; Jedd D. Wolchok, MD, PhD; et al.
JAMA. 2011;305(22):2327-2334. doi:10.1001/jama.2011.746.
INCLUDES: , Supplemental Content
Medical News & Perspectives |  June 08, 2011
Studies Probe Role of Telomere Length in Predicting, Modulating Cancer Risk
Tracy Hampton, PhD
JAMA. 2011;305(22):2278-2279. doi:10.1001/jama.2011.772.
Editorial |  June 01, 2011
The Thin Line Between Hope and Hype in Biomarker Research
Patrick M. M. Bossuyt, PhD
JAMA. 2011;305(21):2229-2230. doi:10.1001/jama.2011.729.
JAMA Patient Page |  June 01, 2011 FREE
BRCA Genes and Breast Cancer
Ryszard M. Pluta, MD, PhD; Robert M. Golub, MD
JAMA. 2011;305(21):2244. doi:10.1001/jama.305.21.2244.
INCLUDES: , Supplemental Content
Medical News & Perspectives |  June 01, 2011
The National Library of Medicine
Anita Slomski
JAMA. 2011;305(21):2158-2161. doi:10.1001/jama.2011.703.
Health Agencies Update |  May 25, 2011
DNA Damage and Immunity
Tracy Hampton, PhD
JAMA. 2011;305(20):2056. doi:10.1001/jama.2011.682.
Medical News & Perspectives |  May 25, 2011
Albany Prize Honors Stem Cell Scientists
Tracy Hampton, PhD
JAMA. 2011;305(20):2054-2055. doi:10.1001/jama.2011.686.
Commentary |  May 11, 2011
The NIH Undiagnosed Diseases Program:  Lessons Learned
William A. Gahl, MD, PhD; Cynthia J. Tifft, MD, PhD
JAMA. 2011;305(18):1904-1905. doi:10.1001/jama.2011.613.
Original Contribution |  May 11, 2011 FREE
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis, PhD; Lajos Pusztai, MD, DPhil; Vicente Valero, MD; et al.
JAMA. 2011;305(18):1873-1881. doi:10.1001/jama.2011.593.
INCLUDES: , Supplemental Content
Lab Reports |  May 04, 2011
Arthritis Target
Tracy Hampton, PhD
JAMA. 2011;305(17):1756. doi:10.1001/jama.2011.545.
Editorial |  April 20, 2011
Whole-Genome Sequencing:  A Step Closer to Personalized Medicine
Boris Pasche, MD, PhD; Devin Absher, PhD
JAMA. 2011;305(15):1596-1597. doi:10.1001/jama.2011.484.
Research Letters |  April 20, 2011 FREE
Real-Time Myoelectric Control of Knee and Ankle Motions for Transfemoral Amputees
Levi J. Hargrove, PhD; Ann M. Simon, PhD; Robert D. Lipschutz, CP; et al.
JAMA. 2011;305(15):1542-1544. doi:10.1001/jama.2011.465.
Preliminary Communication |  April 20, 2011 FREE
Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
Daniel C. Link, MD; Laura G. Schuettpelz, MD, PhD; Dong Shen, MD, PhD; et al.
JAMA. 2011;305(15):1568-1576. doi:10.1001/jama.2011.473.
INCLUDES: , Supplemental Content
Preliminary Communication |  April 20, 2011 FREE
Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion Oncogene
John S. Welch, MD, PhD; Peter Westervelt, MD, PhD; Li Ding, PhD; et al.
JAMA. 2011;305(15):1577-1584. doi:10.1001/jama.2011.497.
INCLUDES: , Supplemental Content
The World in Medicine |  April 20, 2011
Genes for Heart Disease Risk
M. J. Friedrich
JAMA. 2011;305(15):1527. doi:10.1001/jama.2011.476.
Commentary |  April 13, 2011
Epigenetics—The Link Between Infectious Diseases and Cancer
Richard A. Stein, MD, PhD
JAMA. 2011;305(14):1484-1485. doi:10.1001/jama.2011.446.
Lab Reports |  April 06, 2011
Cocaine Gene Alteration
Tracy Hampton, PhD
JAMA. 2011;305(13):1290. doi:10.1001/jama.2011.386.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Phenotypic Conservation in Patients With X-Linked Retinitis Pigmentosa Caused by RPGR Mutations
Sarwar Zahid, MD, MS; Naheed Khan, PhD; Kari Branham, MS; et al.
JAMA Neurology
Clinical Implications of Basic Neuroscience Research  |  May 13, 2013
TRIM Proteins in Therapeutic Membrane Repair of Muscular Dystrophy
Jenna Alloush; Noah Weisleder, PhD
JAMA Neurology
Original Contribution  |  May 13, 2013
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine, MD; Judy Qiang, BA; Emily Ashbridge; et al.
JAMA Ophthalmology
Clinical Trials  |  May 9, 2013
Treatment With 9- cis β-Carotene–Rich Powder in Patients With Retinitis Pigmentosa:  A Randomized Crossover Trial
Ygal Rotenstreich, MD; Michael Belkin, MD; Siegal Sadetzki, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems